Arizona Tribune - News from Phoenix, Arizona, the United States and around the world

WHEAT RIDGE, CO / ACCESS Newswire / August 13, 2026 / Lifeloc Technologies, Inc. (OTCID:LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended June 30, 2026.

Company Reports Record Quarterly Revenues of $54.1 million, a 16.5% Year-Over-Year IncreaseBroadcast Revenues Increase to $45.8 million, a 20.5% Increase Year-Over-YearCompany Reports Net Income of $2.9 million and Adjusted EBITDA of $5.7 million, Its First Profitable Quarter as a Public Company

~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~~ Second Quarter Gross Profit of $0.8 Million, a 232% Increase Compared to Prior Year; Gross Margin of 64% ~~ Received FDA 510(k) Clearance for Updated Catamaran® SI Joint Fusion System ~~ Physician and Distributor Training Events Increased 98% in 1H 2026 Compared to 2H 2025, Supporting Record Monthly Case Volume in July 2026 ~~ Closed $4.2 Million Public Offering Subsequent to Quarter End ~

Veteran patent dealmaker with more than $11 billion in completed intellectual property transactions to lead licensing and monetization of the Company's patented Data Science and Acoustic Science portfolios

Consolidated Revenue and Gross Profit increased by 23% and 36%, respectively.

Systems Integration Revenue Increased 46% Year-Over-Year, Representing 39% of Total Revenue~$17 Million Investment Expected to Drive Increased Systems Integration Revenue from Next Generation AI Data Center Technology

WOBURN, MA / ACCESS Newswire / August 13, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN) a leader in AI-powered marketing technology, today announced financial results for its fiscal 2026 third quarter, which ended June 30, 2026.

SAN DIEGO, CA / ACCESS Newswire / August 13, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2026.

Second quarter 2026 revenue increased 88.4% year-over-year to a record $59.1 millionRecord number of units transacted, 138% year-over-year increase

SEATTLE, WA / ACCESS Newswire / August 13, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today closed its previously announced warrant inducement transaction with certain holders of its existing common warrants (the "Existing Warrants"), pursuant to which such holders have exercised in full for cash their Existing Warrants to purchase up to an aggregate of 254,922 shares of common stock of the Company ("common stock") at a reduced exercise price of $4.03 per share. In consideration for such cash exercises, the Company has issued new unregistered common stock purchase warrants (the "Inducement Warrants") to purchase up to an aggregate of 1,274,610 shares of common stock at an exercise price of $4.03 per share. The Inducement Warrants will be exercisable on or after the date on which the Company obtains the required stockholder approval and will expire on the five-year anniversary of the date of such stockholder approval. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to effective registration statements on Form S-1 (File No. 333-288061), Form S-1MEF (File No. 333-288134), Form S-3 (File No. 333-284969) and Form S-3 (File No. 333-283983).

Delivers Double-Digit Revenue Growth, Gross Margin Above 50%, and Another Record Cash BalanceThis press release replaces the previous press release.

Former MedCerts COO and CPO to Lead Healthcare Growth, Workforce Partnerships and Outcomes Strategy

LOAN GROWTH 13.5%CAPITAL INCREASE 18.3%

A leading national precious metals dealer and the nation's top sound money advocacy group honor Maryland and Alaska lawmakers for advancing sound money policies

QUEBEC, QC / ACCESS Newswire / August 13, 2026 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC Pink:NRRWF)(FSE:1RN), a pioneering rural connectivity company and one of Africa's fastest-growing Network-as-a-Service ("NaaS") operators, is pleased to announce that it has received an approval letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that Nasdaq has approved the Company's application to list its common shares on The Nasdaq Capital Market. Nasdaq has reserved the trading symbol "NUR" for the Company's common shares, and the anticipated date of initial trading on Nasdaq is Monday, August 17, 2026. All amounts in this news release are in Canadian dollars unless otherwise indicated.

JASPER, IN / ACCESS Newswire / August 13, 2026 / SVB&T Corporation (OTCQX:SVBT), parent company of Springs Valley Bank & Trust Company, today announced 2026 second quarter unaudited earnings of $3.04 million or $2.75 basic earnings per share (EPS), a 41.75% increase over the same prior year period earnings on a per share basis. This 2026 second quarter performance translates to a return on average assets (ROAA) of 1.84%, compared to the same prior year period ROAA of 1.34%.

ELEKTROS Inc. - Publicly Traded (Ticker Symbol: ELEK)

Dr. Louis DeJoseph reviews who may benefit from a neck lift and why surgeon credentials, aesthetic style, and realistic expectations matter when considering treatment.

LUBBOCK, TX / ACCESS Newswire / August 13, 2026 / Glo Tanning announces the opening of its newest location in Lubbock, Texas, on August 8, bringing its signature blend of skincare, wellness, and tanning services to the community.

ELEKTROS Inc. - Publicly Traded (Ticker Symbol: ELEK)

WEST PALM BEACH, FL / ACCESS Newswire / August 13, 2026 / ELEKTROS Inc. (OTC PINK:ELEK) today underscored its long-term hard-rock lithium and EV charging strategy against the backdrop of resilient U.S. markets and a rapidly evolving technology-driven economy. Management believes the extraordinary scale of investment flowing into artificial intelligence, data centers, electrification and advanced infrastructure represents a distinctive and potentially transformative moment for the American economy and, by extension, the broader global marketplace.

US$500,000 FNGR Share Consideration Implies Approximately US$5M Lyken Equity Value Based on Transaction Price

TORONTO, ON / ACCESS Newswire / August 13, 2026 / If you've taken even a casual glance at local real estate headlines lately, you already know the story: soaring holding costs, unpredictable interest rate shifts, longer days on market, and buyers taking their sweet time to make an offer. For homeowners across the Greater Toronto Area and major urban hubs in Alberta, selling a home through traditional channels can feel like an exhausting test of endurance.

RICHMOND, VA / ACCESS Newswire / August 13, 2026 / OT Advisors LLC, the investment sub-adviser to the Opportunistic Trader ETF (Ticker: WZRD) (the "Fund"), today announced the execution of a reverse share split of the Fund.

NEW YORK, NY / ACCESS Newswire / August 13, 2026 / Grassi, a leading employee-owned advisory, tax and accounting firm, announced today that Hoffman Mulligan has joined the firm, strengthening its high-net-worth and tax practice capabilities and expanding its presence in New York City.

Chuck Henrich, Owner and President of Southwest Michigan Financial, LLC discusses how to build a solid retirement income plan.

ST. PETERSBURG, FL / ACCESS Newswire / August 13, 2026 / Allelo, the acclaimed Mediterranean-inspired wine bar and restaurant in downtown St. Petersburg, has been named No. 5 Best Wine Bar in the United States in the 2026 USA TODAY 10Best Readers' Choice Awards.

Potential Fourth-Quarter 2026 Decision Could Mark Entolimod's First National Registration and Open a Pathway to Strategic Stockpiling and Government ProcurementFormal review accepted July 22 • Ministry begins technical assessment • Regulatory requirements defined • Potential decision as early as Q4 2026Near-Term Regulatory CatalystFormal review underway: Ukraine's Ministry of Health accepted the Entolimod dossier for formal review on July 22, 2026.Technical assessment underway: Ukraine's Ministry of Health has begun technical assessment of the dossier and issued its first round of questions, relating to the physicochemical characterization of the drug product that would be supplied under a potential stockpiling arrangement.Defined pathway: The Company has identified the analytical testing, quality-control validation, GMP verification, import-documentation, and Ukrainian-language labeling requirements applicable to the registration process.Potential Q4 decision: Valion Bio believes a regulatory decision could occur as early as the fourth quarter of 2026; there can be no assurance regarding timing or outcome.First potential national registration: A favorable decision would represent Entolimod's first national registration.Potential government-market pathway: Registration could establish a pathway toward possible inclusion in Ukraine's national strategic reserves and future government procurement. No procurement, purchase, or stockpiling agreement has been executed.

Fully human dual-antagonist bispecific antibody discovered and engineered at AlivaMab Biologics

Proprietary AI Vision Platform Delivers Rapid Strain Identification and Quality Verification Tools for Licensed Multi-Location Dispensary Operators

Dataset expands by approximately 265 million data points since July 21 as continued AI Nose system deployment across semiconductor manufacturing environments accelerates Ainos' Real-World Data Flywheel and Chemical Intelligence development

The Miami Beach practice offers the same EMSculpt NEO platform recently added to a professional football team's recovery program, including its functional health and rehabilitation protocols.